Jon sits with entrepreneur and Dallas Mavericks minority owner Mark Cuban to discuss his plan to bring more transparency to consumers about the real costs of prescription drugs with his company, Cost Plus Drugs. They also chat about Trump’s desire to be CEO of America and Elon Musk’s role in disrupting global discourse with X algorithms.
See omnystudio.co ... Show More
Nov 21
Epstein Bill Has Trump & Co. Freaking Out & Melania Delivers AI War Cry | Sebastian Maniscalco
Ronny Chieng dives into Trump’s signing of the Epstein Files Transparency Act, Pam Bondi’s shell-shocked statements about a new Epstein investigation aimed at Democrats, U.S. Attorney Lindsey Halligan’s monumental screwup in the Comey case, Grok's ego-stroking of Elon Musk, and M ... Show More
35m 55s
Dec 2024
Reflecting on 2024 with Mark Cuban
As 2024 draws to a close, we're joined by Mark Cuban to reflect on how technology, business, and politics shaped this year. Together we explore his foray into the political arena as a surrogate for Kamala Harris, his mission to disrupt America's healthcare system, and ways govern ... Show More
1h 11m
Apr 2025
EVs, Big Pharma, Tech and the Tariff Threat
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
Sean Tucker, Editor at Kelley Blue Book, joins to discuss the latest on Tesla and the tariff impact. Brad Carson, President of Americas for Responsible Innovation, continues the tariff conversation and the impa ... Show More
43m 59s
Aug 2024
8.22.2024 - Michael Kuczkowski, Orangefiery
<p>Former Edelman San Francisco GM Michael Kuczkowski, who <a href="https://www.prweek.com/article/1283409/former-edelman-sf-gm-launch-consultancy">founded his own shop Orangefiery</a> in 2014, is the special guest on this week’s episode of The PR Week podcast. <br /><br />Kuczko ... Show More
37m 46s
Feb 2025
Checking In On The Housing Market… And The Future of Pharma & Health Care 2/18/25
<p>A check in on the housing market, as builder sentiment drops to a 5-month low. The concerns they have over looming tariffs, and the latest results out of one of the top players in the space. Plus Pharma in focus, as the country’s health agencies deal with funding cuts and pers ... Show More
43m 36s